Parametrica Management LTD Increased Its Oracle (ORCL) Position by $360,250; Market Value Rose; Flow Traders Us Continues to Hold Holding in Credit Suisse Ag/Nassau (ZIV)

November 15, 2017 - By Hazel Jackson

Parametrica Management Ltd increased its stake in Oracle Corp (ORCL) by 96.84% based on its latest 2017Q2 regulatory filing with the SEC. Parametrica Management Ltd bought 7,205 shares as the company’s stock rose 5.35% with the market. The institutional investor held 14,645 shares of the prepackaged software company at the end of 2017Q2, valued at $734,000, up from 7,440 at the end of the previous reported quarter. Parametrica Management Ltd who had been investing in Oracle Corp for a number of months, seems to be bullish on the $205.34 billion market cap company. The stock declined 1.00% or $0.49 reaching $48.71 on the news. About 74,567 shares traded. Oracle Corporation (NYSE:ORCL) has risen 14.08% since November 15, 2016 and is uptrending. It has underperformed by 2.62% the S&P500.

Flow Traders Us Llc increased its stake in Credit Suisse Ag/Nassau (ZIV) by 101.45% based on its latest 2017Q2 regulatory filing with the SEC. Flow Traders Us Llc bought 16,616 shares as the company’s stock rose 12.23% with the market. The institutional investor held 32,994 shares of the investment bankers and brokers and service company at the end of 2017Q2, valued at $2.32 million, up from 16,378 at the end of the previous reported quarter. Flow Traders Us Llc who had been investing in Credit Suisse Ag/Nassau for a number of months, seems to be bullish on the $178.99 million market cap company. The stock declined 0.98% or $0.75 reaching $75.48 on the news. About 620 shares traded. Credit Suisse AG – VelocityShares Daily Inverse VIX Medium Term ETN (NASDAQ:ZIV) has risen 65.76% since November 15, 2016 and is uptrending. It has outperformed by 49.06% the S&P500.

More important recent Oracle Corporation (NYSE:ORCL) news were published by: Medgadget.com which released: “Global Clinical Trial Management System Market 2017 – Mednet Solutions, Oracle …” on November 15, 2017, also Seekingalpha.com published article titled: “Why You Should Buy Oracle Sooner Rather Than Later”, Nasdaq.com published: “Is Oracle Corporation (ORCL) a Great Stock for Value Investors?” on November 13, 2017. More interesting news about Oracle Corporation (NYSE:ORCL) was released by: Benzinga.com and their article: “Vetr Upgrades Oracles” with publication date: November 13, 2017.

Among 38 analysts covering Oracle (NYSE:ORCL), 28 have Buy rating, 0 Sell and 10 Hold. Therefore 74% are positive. Oracle had 97 analyst reports since July 30, 2015 according to SRatingsIntel. Macquarie Research initiated Oracle Corporation (NYSE:ORCL) on Tuesday, April 26 with “Outperform” rating. UBS maintained Oracle Corporation (NYSE:ORCL) on Wednesday, March 16 with “Buy” rating. The rating was maintained by BMO Capital Markets with “Outperform” on Friday, September 16. KeyBanc Capital Markets maintained the stock with “Buy” rating in Monday, July 17 report. Evercore upgraded the stock to “Buy” rating in Wednesday, January 6 report. The rating was maintained by Raymond James with “Buy” on Friday, September 15. William Blair maintained Oracle Corporation (NYSE:ORCL) on Friday, September 15 with “Hold” rating. The firm earned “Market Perform” rating on Friday, January 8 by BMO Capital Markets. The firm has “Buy” rating by Canaccord Genuity given on Thursday, September 14. Credit Suisse maintained it with “Buy” rating and $62.0 target in Thursday, October 12 report.

Parametrica Management Ltd, which manages about $106.58 million US Long portfolio, decreased its stake in Icon Plc (NASDAQ:ICLR) by 4,270 shares to 2,494 shares, valued at $244,000 in 2017Q2, according to the filing.

Investors sentiment is 0.95 in Q2 2017. Its the same as in 2017Q1. It is flat, as 49 investors sold ORCL shares while 572 reduced holdings. only 140 funds opened positions while 449 raised stakes. 2.35 billion shares or 0.02% less from 2.35 billion shares in 2017Q1 were reported. M&T National Bank & Trust Corp has 0.39% invested in Oracle Corporation (NYSE:ORCL) for 1.33M shares. Amg National Tru Financial Bank reported 46,354 shares stake. Schnieders Management Lc owns 8,805 shares or 0.2% of their US portfolio. Bremer Trust Association has invested 0.12% of its portfolio in Oracle Corporation (NYSE:ORCL). Stock Yards State Bank Communication owns 44,677 shares for 0.27% of their portfolio. Cape Cod Five Cents Bank accumulated 12,133 shares. Mark Sheptoff Financial Planning Lc has 0.24% invested in Oracle Corporation (NYSE:ORCL). Davenport Ltd owns 125,851 shares or 0% of their US portfolio. Huntington Bancshares holds 0.56% or 631,153 shares. Pictet North America Advisors has 0.37% invested in Oracle Corporation (NYSE:ORCL). Tennessee-based Diversified Tru Co has invested 0.03% in Oracle Corporation (NYSE:ORCL). Guardian LP has invested 0.02% in Oracle Corporation (NYSE:ORCL). Advisor Limited Liability Corp holds 0.71% or 60,509 shares. Sii Invs Wi holds 107,622 shares or 0.33% of its portfolio. 82,328 were reported by Roanoke Asset Corp New York.

More notable recent Credit Suisse AG – VelocityShares Daily Inverse VIX Medium Term ETN (NASDAQ:ZIV) news were published by: Seekingalpha.com which released: “Beware The Sweet Siren Song Of XIV” on April 16, 2013, also Prnewswire.com with their article: “Credit Suisse Announces the Listing Transfer of Twelve VelocitySharesâ„¢ ETNs …” published on November 19, 2013, Seekingalpha.com published: “How Does VelocityShares Daily Inverse VIX Short-Term ETN Work?” on May 14, 2014. More interesting news about Credit Suisse AG – VelocityShares Daily Inverse VIX Medium Term ETN (NASDAQ:ZIV) were released by: Prnewswire.com and their article: “Credit Suisse AG Announces the Reverse Splits of its DGAZ, VIIX, TVIX and TVIZ …” published on March 09, 2017 as well as Seekingalpha.com‘s news article titled: “Is XIV The Place To Be If Markets Stabilize And Volatility Declines?” with publication date: September 17, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com